Back to User profile » Dr Fei Tong
Papers published by Dr Fei Tong:
Endogenous Ornithine Decarboxylase/Polyamine System Mediated the Antagonist Role of Insulin/PEG-CMCS Preconditioning against Heart Ischemia/Reperfusion Injury in Diabetes Mellitus [Retraction]
Tong F, Liu S, Yan B, Li X, Ruan S, Yang S
International Journal of Nanomedicine 2024, 19:6279-6280
Published Date: 21 June 2024
In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction]
Shan F, Liu Y, Jiang H, Tong F
International Journal of Nanomedicine 2022, 17:2609-2610
Published Date: 10 June 2022
Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICACAM-1 on endothelium [Corrigendum]
Tong F, Liu S, Yan B, Li X, Ruan S, Yang S
International Journal of Nanomedicine 2022, 17:2503-2504
Published Date: 2 June 2022
In vitro/vivo Drug Release and Anti-Diabetic Cardiomyopathy Properties of Curcumin/PBLG-PEG-PBLG Nanoparticles [Retraction]
Tong F, Chai R, Jiang H, Dong B
International Journal of Nanomedicine 2021, 16:3579-3580
Published Date: 25 May 2021
Phycocyanin/PEG-b-(PG-g-PEI) attenuated hepatic ischemia/reperfusion-induced pancreatic islet injury and enlarged islet functionality
Tong F, Tang X, Liu D
International Journal of Nanomedicine 2019, 14:339-351
Published Date: 3 January 2019
Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer
Hu B, Yan Y, Tong F, Xu L, Zhu J, Xu G, Shen R
International Journal of Nanomedicine 2018, 13:3625-3640
Published Date: 26 June 2018
RETRACTED ARTICLE: Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
Tong F, Liu S, Yan B, Li X, Ruan S, Yang S
International Journal of Nanomedicine 2018, 13:2507-2520
Published Date: 23 April 2018
In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles
Tong F, Chai R, Jiang H, Dong B
International Journal of Nanomedicine 2018, 13:1945-1962
Published Date: 3 April 2018
Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
Tong F, Liu S, Yan B, Li X, Ruan S, Yang S
International Journal of Nanomedicine 2017, 12:7799-7813
Published Date: 24 October 2017
In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(L-lysine) nanoparticles
Shan F, Liu Y, Jiang H, Tong F
International Journal of Nanomedicine 2017, 12:7613-7625
Published Date: 17 October 2017
Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(L-lysine) block copolymer: potential implications on diabetic nephropathy
Tong F
International Journal of Nanomedicine 2017, 12:4663-4678
Published Date: 29 June 2017
Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats
Tong F, Dong B, Chai R, Tong K, Wang Y, Chen S, Zhou X, Liu D
International Journal of Nanomedicine 2017, 12:2477-2488
Published Date: 29 March 2017
PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
Xu G, Gu H, Hu B, Tong F, Liu D, Yu X, Zheng Y, Gu J
International Journal of Nanomedicine 2017, 12:2243-2254
Published Date: 23 March 2017
The effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(L-lysine) block copolymer on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor
Tong F, Tang XY, Li X, Xia WQ, Liu DJ
International Journal of Nanomedicine 2016, 11:1717-1730
Published Date: 27 April 2016